Evidence map›Paper›PMID 41450473›Full record

ArticleChemical & biomedical imaging2025

USSGAN: Unsupervised Spectral and Spatial Attention-Based Generative Adversarial Network for Cholangiocarcinoma Detection.

Sikhakolli Sravan Kumar, Anuj Deshpande, Pooja A Nair, Suresh Aala, Sunil Chinnadurai, Vineela Chandra Dodda, Inbarasan Muniraj, Md Abdul Latif Sarker, Hala Mostafa

Abstract read
In one paragraph

Article in Chemical & biomedical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sikhakolli Sravan KumarElectronics and Communication Department, SRM University-AP, Mangalagiri, Andhra Pradesh 522240, India.ORCID https://orcid.org/0000-0002-4887-997X
Anuj DeshpandeElectronics and Communication Department, SRM University-AP, Mangalagiri, Andhra Pradesh 522240, India.ORCID https://orcid.org/0000-0002-7415-1691
Pooja A NairElectronics and Communication Department, SRM University-AP, Mangalagiri, Andhra Pradesh 522240, India.ORCID https://orcid.org/0000-0002-1937-0509
Suresh AalaElectronics and Communication Department, SRM University-AP, Mangalagiri, Andhra Pradesh 522240, India.
Sunil ChinnaduraiElectronics and Communication Department, SRM University-AP, Mangalagiri, Andhra Pradesh 522240, India.
Vineela Chandra DoddaDepartment of Electronics and Communication Engineering, Amrita School of Engineering Amaravati, Amrita Vishwa Vidyapeetham, Guntur, Andhra Pradesh 522503, India.ORCID https://orcid.org/0000-0001-7324-2949
Inbarasan MunirajDepartment of Electronic Engineering, Maynooth University, Maynooth, Co. Kildare W23 V5XH, Ireland.
Md Abdul Latif SarkerDepartment of Electronics and Information Engineering, Jeonbuk National University, Jeonju 54896, Korea.
Hala MostafaDepartment of Information Technology, College of Computer and Information Sciences, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cholangiocarcinoma, a form of liver bile duct cancer, is challenging to detect due to its critically low 5-year survival rate. Conventional imaging modalities, such as Computed Tomography (CT) and Magnetic Resonance Imaging (MRI), are widely used, but recent advancements in Hyperspectral Imaging (HSI) offer a promising, non-invasive alternative for cancer diagnosis. However, supervised learning methods often require large annotated datasets that can be difficult to obtain. To alleviate this limitation, we propose an unsupervised learning strategy using Generative Adversarial Networks (GANs) for cholangiocarcinoma detection. This approach, named Unsupervised Spectral and Spatial Attention-based GAN (USSGAN), employs an unsupervised Spectral-Spatial attention-based GAN to classify and segment cancerous regions without relying on labeled training data. The integration of an adaptive step size into Tasmanian Devil Optimization (TDO) enhances the convergence speed and effectively captures diverse cancerous features. Enhanced Tasmanian Devil Optimization (ETDO) further improves segmentation performance, making the framework robust and computationally efficient. The proposed method was tested on a publicly available multidimensional choledochal cholangiocarcinoma dataset, achieving superior performance compared with existing techniques in the literature. USSGAN demonstrated high accuracy across key metrics such as overall accuracy (OA), average accuracy (AA), and Cohen's Kappa. Ablation studies confirmed the critical contributions of the proposed enhancements to the overall performance. With an overall accuracy of 98.03%, the USSGAN closely aligns with the assessments of experienced pathologists while maintaining minimal computational requirements. Its lightweight nature ensures real-time deployment, providing results within a minute, making it a practical and effective solution for clinical applications.

Indexed as

cholangiocarcinomaenhanced tasmanian devil optimizationgenerative adversarial networkshyperspectral imagingunsupervised learning

Identifiers

PMID41450473
PMCPMC12728757

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.